NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
29
GSK Quote, Financials, Valuation and Earnings
Last price:
$34.07
Seasonality move
:
4.52%
Day range:
$33.04 - $33.87
52-week range:
$32.83 - $45.93
Dividend yield:
4.66%
P/E ratio:
21.84x
P/S ratio:
1.74x
P/B ratio:
3.66x
Volume:
6.8M
Avg. volume:
5.6M
1-year change:
-7.16%
Market cap:
$68.6B
Revenue:
$37.7B
EPS (TTM):
$1.54
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $43.1B | $31.3B | $34B | $36.3B | $37.7B | |
| Revenue Growth (YoY) | 4.81% | -27.48% | 8.7% | 6.88% | 3.92% | |
| Cost of Revenues | $15.1B | $10.2B | $11.2B | $11.8B | $10.7B | |
| Gross Profit | $28B | $21.1B | $22.7B | $24.5B | $27.1B | |
| Gross Profit Margin | 64.86% | 67.44% | 66.95% | 67.42% | 71.76% | |
| R&D Expenses | $5.8B | $6.2B | $6.9B | $6.8B | $7.7B | |
| Selling, General & Admin | $14.6B | $9.5B | $9.7B | $10.4B | $11.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $19.9B | $15.2B | $16B | $16.1B | $17.9B | |
| Operating Income | $8B | $5.9B | $6.7B | $8.3B | $9.1B | |
| Net Interest Expenses | $1.1B | $1.1B | $1B | $1B | $914.6M | |
| EBT. Incl. Unusual Items | $7.9B | $6.6B | $5B | $7B | $7.5B | |
| Earnings of Discontinued Ops. | -- | $1.6B | $2.2B | $13.3B | -- | |
| Income Tax Expense | $1.2B | $86M | $114.2M | $875.5M | $940.7M | |
| Net Income to Company | $6.7B | $6.5B | $4.8B | $6.1B | $6.6B | |
| Minority Interest in Earnings | -$795.5M | -$820.1M | -$978.2M | -$823.5M | -$472.8M | |
| Net Income to Common Excl Extra Items | $5.9B | $7.4B | $6B | $18.5B | $6.1B | |
| Basic EPS (Cont. Ops) | $3.00 | $3.71 | $3.02 | $9.20 | $3.03 | |
| Diluted EPS (Cont. Ops) | $2.96 | $3.66 | $2.98 | $9.07 | $2.98 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2B | $2.1B | |
| EBITDA | $12B | $10.4B | $8.9B | $10.7B | $11.3B | |
| EBIT | $9.1B | $7.7B | $6B | $8B | $8.4B | |
| Revenue (Reported) | $43.1B | $31.3B | $34B | $36.3B | $37.7B | |
| Operating Income (Reported) | $8B | $5.9B | $6.7B | $8.3B | $9.1B | |
| Operating Income (Adjusted) | $9.1B | $7.7B | $6B | $8B | $8.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.2B | $9.1B | $9.2B | $10.3B | $10.4B | |
| Revenue Growth (YoY) | -3.38% | -18.22% | 0.84% | 11.96% | 1.06% | |
| Cost of Revenues | $3.7B | $2.8B | $2.9B | $2.9B | $3.1B | |
| Gross Profit | $7.4B | $6.4B | $6.4B | $7.4B | $7.3B | |
| Gross Profit Margin | 66.63% | 69.58% | 69.05% | 72.11% | 70.08% | |
| R&D Expenses | $1.5B | $2B | $1.6B | $2B | $1.9B | |
| Selling, General & Admin | $3.4B | $2.3B | $2.4B | $2.9B | $4.9B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $5B | $4.5B | $5B | $5B | $7.1B | |
| Operating Income | $2.4B | $1.9B | $1.4B | $2.5B | $245.9M | |
| Net Interest Expenses | $255.9M | $263.3M | $209.5M | $200.1M | $161.4M | |
| EBT. Incl. Unusual Items | $2.2B | $1.6B | $1.2B | $2.3B | $83.3M | |
| Earnings of Discontinued Ops. | -- | $581.8M | $11.9B | -- | -- | |
| Income Tax Expense | $311.4M | $339.2M | $274.2M | $325.4M | -$1.3M | |
| Net Income to Company | $2.1B | $1.3B | $714.9M | $2B | $178.9M | |
| Minority Interest in Earnings | -$240.4M | -- | -$44.7M | -$88.6M | -$160.1M | |
| Net Income to Common Excl Extra Items | $1.6B | $1.9B | $12.7B | $1.9B | -$75.5M | |
| Basic EPS (Cont. Ops) | $0.81 | $0.81 | $6.32 | $0.91 | -$0.04 | |
| Diluted EPS (Cont. Ops) | $0.80 | $0.79 | $6.23 | $0.90 | -$0.04 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2.1B | $2.1B | |
| EBITDA | $3.2B | $3.2B | $2.6B | $3.2B | $1.5B | |
| EBIT | $2.4B | $1.9B | $1.4B | $2.5B | $286.3M | |
| Revenue (Reported) | $11.2B | $9.1B | $9.2B | $10.3B | $10.4B | |
| Operating Income (Reported) | $2.4B | $1.9B | $1.4B | $2.5B | $245.9M | |
| Operating Income (Adjusted) | $2.4B | $1.9B | $1.4B | $2.5B | $286.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $43.7B | $26.2B | $37.1B | $36.4B | $39.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $15B | $7.8B | $13B | $10.3B | $11.3B | |
| Gross Profit | $28.7B | $18.4B | $24.1B | $26.1B | $28.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.2B | $6.7B | $6.5B | $7.3B | $8.1B | |
| Selling, General & Admin | $15B | $6.9B | $10.4B | $11.2B | $14B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $18.6B | $15.2B | $16.9B | $15.9B | $22.7B | |
| Operating Income | $10.1B | $3.2B | $7.2B | $10.2B | $5.7B | |
| Net Interest Expenses | $1.1B | $1.1B | $957.3M | $915.8M | $832.3M | |
| EBT. Incl. Unusual Items | $10B | $3.9B | $5.5B | $9B | $4.2B | |
| Earnings of Discontinued Ops. | -- | $955M | $13.4B | -$5.9M | -- | |
| Income Tax Expense | $1B | -$286.7M | $738.4M | $965M | $563.6M | |
| Net Income to Company | $9.3B | $3.6B | $4.4B | $8.4B | $3.6B | |
| Minority Interest in Earnings | -$886.8M | -$671.4M | -$706.7M | -$558.5M | -$429.3M | |
| Net Income to Common Excl Extra Items | $8.1B | $6.2B | $16.5B | $7.5B | $3.2B | |
| Basic EPS (Cont. Ops) | $4.07 | $2.97 | $8.45 | $3.69 | $1.56 | |
| Diluted EPS (Cont. Ops) | $4.03 | $2.93 | $8.33 | $3.64 | $1.54 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $12.1B | $10.7B | $9.8B | $12B | $8.5B | |
| EBIT | $11B | $5B | $6.5B | $9.9B | $5B | |
| Revenue (Reported) | $43.7B | $26.2B | $37.1B | $36.4B | $39.7B | |
| Operating Income (Reported) | $10.1B | $3.2B | $7.2B | $10.2B | $5.7B | |
| Operating Income (Adjusted) | $11B | $5B | $6.5B | $9.9B | $5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $32.3B | $27.5B | $27.6B | $27.7B | $29.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.9B | $8.6B | $9.2B | $7.7B | $8.3B | |
| Gross Profit | $21.4B | $18.9B | $18.3B | $20.1B | $21.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.6B | $5.1B | $4.6B | $5.2B | $5.6B | |
| Selling, General & Admin | $10.5B | $8B | $7.4B | $8.4B | $10.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $12.9B | $12.9B | $12.5B | $12.4B | $17.2B | |
| Operating Income | $8.5B | $6B | $5.8B | $7.7B | $4.2B | |
| Net Interest Expenses | $779.6M | $785.2M | $705.2M | $601.8M | $520.6M | |
| EBT. Incl. Unusual Items | $7.8B | $5.2B | $5.1B | $7.1B | $3.7B | |
| Earnings of Discontinued Ops. | -- | $955M | $12.7B | -- | -- | |
| Income Tax Expense | $760.6M | $413.9M | $896.2M | $963.8M | $587.2M | |
| Net Income to Company | $7.2B | $4.3B | $3.9B | $6.2B | $3.2B | |
| Minority Interest in Earnings | -$606M | -$457.7M | -$706.7M | -$411.5M | -$369.7M | |
| Net Income to Common Excl Extra Items | $6.4B | $5.3B | $16.2B | $5.7B | $2.7B | |
| Basic EPS (Cont. Ops) | $3.23 | $2.52 | $7.94 | $2.81 | $1.34 | |
| Diluted EPS (Cont. Ops) | $3.19 | $2.49 | $7.84 | $2.78 | $1.33 | |
| Weighted Average Basic Share | $6B | $6B | $6.5B | $6.1B | $6.1B | |
| Weighted Average Diluted Share | $6B | $6.1B | $6.6B | $6.1B | $6.2B | |
| EBITDA | $9.7B | $8.6B | $8.7B | $9.9B | $7.1B | |
| EBIT | $8.6B | $6B | $5.9B | $7.8B | $4.3B | |
| Revenue (Reported) | $32.3B | $27.5B | $27.6B | $27.7B | $29.7B | |
| Operating Income (Reported) | $8.5B | $6B | $5.8B | $7.7B | $4.2B | |
| Operating Income (Adjusted) | $8.6B | $6B | $5.9B | $7.8B | $4.3B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.9B | $8.3B | $5.5B | $4.3B | $3.5B | |
| Short Term Investments | $103.6M | $106.3M | $82.3M | $5B | $2.9B | |
| Accounts Receivable, Net | $7.2B | $7.6B | $8.4B | $6.6B | $7.5B | |
| Inventory | $7.8B | $8.2B | $7.8B | $6.2B | $7B | |
| Prepaid Expenses | $414.3M | $489.3M | $425.1M | $415.1M | $452.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $25.6B | $27.6B | $25.2B | $25.1B | $23.8B | |
| Property Plant And Equipment | $14.8B | $15B | $14.4B | $11.6B | $12.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $13.8B | $14.4B | $14.2B | $8.5B | $8.7B | |
| Other Intangibles | $40.6B | $40.6B | $40.6B | $17.3B | $18.8B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $104.5B | $109.6B | $106.8B | $72.8B | $75.2B | |
| Accounts Payable | $5.4B | $5.9B | $6.1B | $4.7B | $4.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $314.7M | $313.5M | $274M | $202.1M | $198.7M | |
| Other Current Liabilities | $989.9M | $1B | $1.3B | $1.6B | $1.3B | |
| Total Current Liabilities | $31.5B | $30.2B | $31.9B | $27.6B | $26.8B | |
| Long-Term Debt | $29.6B | $30.7B | $26.7B | $19.6B | $18B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $80.4B | $81.3B | $78B | $60.6B | $58.9B | |
| Common Stock | $1.8B | $1.8B | $1.8B | $1.6B | $1.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $15B | $19.9B | $20.3B | $12.8B | $17B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $9.1B | $8.5B | $8.5B | -$607.5M | -$703.2M | |
| Total Equity | $24.1B | $28.4B | $28.8B | $12.2B | $16.3B | |
| Total Liabilities and Equity | $104.5B | $109.6B | $106.8B | $72.8B | $75.2B | |
| Cash and Short Terms | $6B | $8.4B | $5.6B | $9.3B | $6.4B | |
| Total Debt | $38.4B | $35.5B | $31.3B | $24.2B | $21.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.5B | $4.6B | $4B | $3.9B | $4.3B | |
| Short Term Investments | $106.8M | $81.9M | $4B | $4.3B | $26.8M | |
| Accounts Receivable, Net | $10.1B | $10.3B | $8.4B | $10.4B | $9.9B | |
| Inventory | $8.3B | $8.4B | $5.2B | $6.7B | $7.9B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $25.6B | $24.5B | $22.6B | $25.9B | $23.1B | |
| Property Plant And Equipment | $14.4B | $14.3B | $10.8B | $11.5B | $13B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $14B | $14.2B | $8B | $8.5B | $8.9B | |
| Other Intangibles | $39.4B | $40.6B | $17.4B | $18.7B | $20.1B | |
| Other Long-Term Assets | $1.2B | $1.7B | $1.3B | $1.4B | $2.6B | |
| Total Assets | $104.1B | $105.7B | $67.4B | $74.3B | $77.7B | |
| Accounts Payable | $19.5B | $20.4B | $18B | $19B | $19.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $998.2M | $1B | $1.1B | $1.2B | $1.5B | |
| Total Current Liabilities | $28.5B | $30.1B | $23.4B | $27.3B | $28.7B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $77.6B | $76.5B | $57.6B | $58.9B | $59.7B | |
| Common Stock | $1.7B | $1.8B | $1.5B | $1.6B | $1.8B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.2B | $8.5B | -$486.9M | -$627.1M | -$742.7M | |
| Total Equity | $26.5B | $29.2B | $9.7B | $15.4B | $18B | |
| Total Liabilities and Equity | $104.1B | $105.7B | $67.4B | $74.3B | $77.7B | |
| Cash and Short Terms | $5.6B | $4.7B | $8B | $8.2B | $4.3B | |
| Total Debt | $36.3B | $34.4B | $24.7B | $25.4B | $21.5B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.7B | $6.5B | $4.8B | $6.1B | $6.6B | |
| Depreciation & Amoritzation | $3B | $2.6B | $2.9B | $2.7B | $2.9B | |
| Stock-Based Compensation | $466.1M | $432.5M | $471.9M | $428.5M | $382M | |
| Change in Accounts Receivable | -$245.2M | -$806M | -$1.6B | -$762.8M | -$807.6M | |
| Change in Inventories | $383.1M | $128.3M | $70.2M | -$333.1M | -$527.6M | |
| Cash From Operations | $10.2B | $10.8B | $10.9B | $9.2B | $8.4B | |
| Capital Expenditures | $2.8B | $2.5B | $3.7B | $2.8B | $2.9B | |
| Cash Acquisitions | -$4.8B | $3.7B | $254.5M | -$3.9B | $362.1M | |
| Cash From Investing | -$6.8B | $2.8B | -$2.4B | -$10.9B | -$2B | |
| Dividends Paid (Ex Special Dividend) | -$5B | -$5.1B | -$5.5B | -$4.3B | -$2.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10.1B | $4.2B | $414.1M | $2.5B | $277.5M | |
| Long-Term Debt Repaid | -$5.3B | -$9.4B | -$3.2B | -$8.3B | -$3.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$247.7M | -$866.3M | -$572.3M | $13B | $424.3M | |
| Cash From Financing | -$2.3B | -$13B | -$10.4B | $1B | -$7B | |
| Beginning Cash (CF) | $5.2B | $6.2B | $7.2B | $4.7B | $4.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.1B | $603.2M | -$1.9B | -$676.1M | -$582.3M | |
| Ending Cash (CF) | $6.2B | $6.8B | $5.3B | $4.2B | $3.6B | |
| Levered Free Cash Flow | $7.5B | $8.3B | $7.3B | $6.4B | $5.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | $1.3B | $714.9M | $2B | $178.9M | |
| Depreciation & Amoritzation | $777.7M | $1.2B | $1B | $749.1M | $1.3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.3B | $3.5B | $1.2B | $2.8B | $2.9B | |
| Capital Expenditures | $876.3M | $1.6B | $482.5M | $644.9M | $1.1B | |
| Cash Acquisitions | $222.6M | -$51.7M | -$3.5B | -$101.1M | $36.4M | |
| Cash From Investing | -$579.1M | -$1.6B | -$4.5B | -$641.8M | -$926.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.3B | -$1.3B | -$660.6M | -$734.2M | -$844.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $95.6M | -- | $956.8M | -$746M | -- | |
| Long-Term Debt Repaid | -$3.8B | -$303.5M | -$2.1B | -$554.9M | -$747.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$56.4M | -$91.4M | $252.1M | -$7.3M | $132.1M | |
| Cash From Financing | -$5.7B | -$1.9B | -$1.8B | -$2.2B | -$1.7B | |
| Beginning Cash (CF) | $9.5B | $4.5B | $9.3B | $3.8B | $3.6B | |
| Foreign Exchange Rate Adjustment | -$56.7M | $18.6M | $20.4M | $27.8M | -$45.3M | |
| Additions / Reductions | -$5B | $17.9M | -$5.1B | -$56.3M | $240M | |
| Ending Cash (CF) | $4.7B | $4.4B | $3.9B | $3.8B | $3.9B | |
| Levered Free Cash Flow | $430.6M | $1.9B | $737M | $2.2B | $1.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.3B | $3.6B | $4.4B | $8.4B | $3.6B | |
| Depreciation & Amoritzation | -$492.1M | $5.6B | $3.1B | $2.1B | $3.5B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.5B | $10.7B | $11.6B | $7.2B | $9.4B | |
| Capital Expenditures | $2.8B | $3.6B | $2.5B | $3B | $3.3B | |
| Cash Acquisitions | $3.6B | $226.4M | -$3.7B | -$1B | $3.1B | |
| Cash From Investing | $2.2B | -$2B | -$10.2B | -$3.5B | $231.2M | |
| Dividends Paid (Ex Special Dividend) | -$5.3B | -$5.4B | -$4.6B | -$3.1B | -$3.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$7.6B | -$2.7B | -$8.3B | -$3.9B | -$3.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $66.5M | -$1.7B | $12B | $1.2B | $428.1M | |
| Cash From Financing | -$13.8B | -$9.4B | -$1.3B | -$4.1B | -$9.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.1B | -$721.3M | $201.3M | -$432.3M | $148.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.7B | $7.1B | $9.1B | $4.2B | $6.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $4.3B | $3.9B | $6.2B | $3.2B | |
| Depreciation & Amoritzation | -$426.4M | $2.5B | $2.7B | $2.1B | $2.8B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.9B | $5.8B | $6.5B | $4.5B | $5.5B | |
| Capital Expenditures | $1.8B | $2.9B | $1.8B | $2B | $2.4B | |
| Cash Acquisitions | $3.7B | $300.6M | -$3.7B | -$844.6M | $1.9B | |
| Cash From Investing | $2.9B | -$2B | -$9.7B | -$2.4B | -$143.1M | |
| Dividends Paid (Ex Special Dividend) | -$3.9B | -$4.2B | -$3.3B | -$2.1B | -$2.4B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3B | -- | $956.8M | $2.1B | -- | |
| Long-Term Debt Repaid | -$7.5B | -$798.3M | -$5.9B | -$1.6B | -$1.8B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $292M | -$570.8M | $12B | $231.7M | $235.5M | |
| Cash From Financing | -$10.3B | -$6.6B | $2.5B | -$2.6B | -$5.1B | |
| Beginning Cash (CF) | $21.8B | $17.4B | $28.9B | $11.3B | $10.5B | |
| Foreign Exchange Rate Adjustment | -$22M | -$29M | $124.8M | -$82.3M | -$79.4M | |
| Additions / Reductions | -$1.5B | -$2.8B | -$674.4M | -$430.5M | $300.6M | |
| Ending Cash (CF) | $20.3B | $14.6B | $27.7B | $10.9B | $10.9B | |
| Levered Free Cash Flow | $4.1B | $2.9B | $4.7B | $2.5B | $3.1B | |
Get GSK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GSK
Sector
P/E ratio
21.84x
25.86x
PEG ratio
--
0.00x
P/B ratio
3.66x
1.84x
Price / LTM sales
1.74x
1.86x
Growth Metrics
GSK
Sector
Revenue growth
1.06%
7.1%
Earnings growth
-27.64%
1.82%
Revenue (5-year growth)
-1.7%
8.72%
Earnings forecast
$1.16
-$0.20
Profitability
GSK
Sector
Profitability FY 2023
$27.1B
$57.1M
Return on invested capital
8.08%
-14.09%
Return on assets
4.23%
-11.79%
Return on equity
18.89%
-14.85%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
29
Balance Sheet
GSK
Sector
Total cash
$4.3B
$46.9M
Short term investments
$2.9B
$44M
Total assets
$75.2B
$142M
Long term debt
$21.5B
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
